| abstract |
Disclosed are benzodioxepins of formula (I) and the physiologically acceptab le salts and solvates thereof, R1, R2, R3, R4, A, B, a, and b having the meanin gs indicated in claim 1. Said benzodioxepins are ligands of the 5HT1A receptors and/or 5HT4 receptors while greatly inhibiting serotonin reuptake. The inventive benzodioxepins can be used for the treatment and prophylaxis of different diseases. |